BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
See today's BioWorld Asia
Home
» Hainan Haiyao branches out, sets up $20M fund to buy into innovation
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Hainan Haiyao branches out, sets up $20M fund to buy into innovation
April 2, 2014
By
Shannon Ellis
No Comments
SHANGHAI – Hainan Haiyao Co. Ltd., of Haikou, China, revealed in a regulatory filing that is has some cash to spend and is seeking to buy its way into some new opportunities, with biotechs at the top of its list.
BioWorld Asia